Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
New England Journal of MedicinePublished 1 August 1991Open access
The SOLVD Investigators*
Citations8,006
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
Abstract
The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
Keywords
Medicine
Journal of the Royal Statistical Society Series B (Statistical Methodology)Regression Models and Life-Tables
39,259 Citations1972D. R. Cox
Journal of the American Statistical AssociationNonparametric Estimation from Incomplete Observations
39,052 Citations1958Edward L. Kaplan, Paul Meier
British Journal of CancerDesign and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
8,392 Citations1977Richard Peto, M. C. Pike +8 more
Efficient methods of analysis of randomized clinical trials in which the authors wish to compare the duration of survival among different groups of patients are described.
Journal of the American Society of EchocardiographyRecommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
8,141 Citations1989Nelson B. Schiller, Pravin M. Shah +10 more
New England Journal of MedicineEffects of Enalapril on Mortality in Severe Congestive Heart Failure
5,077 Citations1987The Consensus Trial Study Group*
It is concluded that the addition of enalapril to conventional therapy in patients with severe congestive heart failure can reduce mortality and improve symptoms and a significant improvement in NYHA classification was observed in the enAlapril group.
New England Journal of MedicineThe Natural History of Congestive Heart Failure: The Framingham Study
3,478 Citations1971Patrick A. McKee, William P. Castelli +2 more
The natural history of congestive heart failure was studied over a 16-year period in 5192 persons initially free of the disease, finding that in almost every five-year age group, from 30 to 62 years, the incidence rate was greater for men than for women.
New England Journal of MedicineEffect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
2,413 Citations1986Jay N. Cohn, Donald Archibald +16 more
The data suggest that the addition of hydralazine and isosorbide dinitrate to the therapeutic regimen of digoxin and diuretics in patients with chronic congestive heart failure can have a favorable effect on left ventricular function and mortality.
CirculationComparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
1,386 Citations1990Gary S. Francis, Claude R. Benedict +7 more
It is concluded that neuroendocrine activation occurs in patients with left ventricular dysfunction and no heart failure, and is further increased as overt heart failure ensues and diuretics are added to therapy.
Journal of the American College of CardiologyA placebo-controlled trial of captopril in refractory chronic congestive heart failure
589 Citations1983
It was concluded that captopril is an effective adjunctive treatment to digitalis and diuretic drugs for patients with refractory heart failure.
CirculationImmediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
292 Citations1980Robert Ader, Kanu Chatterjee +4 more
It is suggested that captopril may be a useful therapeutic adjunct for the long-term management of patients with chronic congestive heart failure.
The American Journal of CardiologyStudies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction
186 Citations1990The SOLVD Investigators
The rationale and design of a tiered approach to clinical trials that are large enough to provide reliable information on mortality and morbidity, yet provide relevant information on other endpoints are described.
HypertensionChanges in hypertension treatment and in congestive heart failure mortality in the United States.
150 Citations1989Salim Yusuf, T J Thom +1 more
It is speculated that antihypertensive treatment does not completely prevent congestive heart failure but merely postpones its development by several decades.
The American Journal of CardiologyEffect of drug therapy on survival in chronic congestive heart failure
51 Citations1988Curt D. Furberg, Salim Yusuf
A review of the current evidence on the effects of various agents on survival among patients with congestive heart failure suggests that angiotensin-converting enzyme inhibitors probably offer the greatest potential for benefit, while the large data base on alpha-adrenergic blockers suggests that these drugs are not likely to improve survival.